Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Characterization of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Strains Involved in Maternal-Fetal Colonization: Prevalence of E. coli ST131

André Birgy, Patricia Mariani-Kurkdjian, Philippe Bidet, Catherine Doit, Nathalie Genel, Céline Courroux, Guillaume Arlet, Edouard Bingen
André Birgy
aLaboratoire de Microbiologie, Hôpital Robert Debré, Service de Microbiologie, Assistance Publique des Hôpitaux de Paris, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Mariani-Kurkdjian
aLaboratoire de Microbiologie, Hôpital Robert Debré, Service de Microbiologie, Assistance Publique des Hôpitaux de Paris, Paris, France
bUniversité Paris Diderot, Sorbonnes Paris Cité, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Bidet
aLaboratoire de Microbiologie, Hôpital Robert Debré, Service de Microbiologie, Assistance Publique des Hôpitaux de Paris, Paris, France
bUniversité Paris Diderot, Sorbonnes Paris Cité, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Doit
aLaboratoire de Microbiologie, Hôpital Robert Debré, Service de Microbiologie, Assistance Publique des Hôpitaux de Paris, Paris, France
bUniversité Paris Diderot, Sorbonnes Paris Cité, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Genel
cUniversité Pierre et Marie Curie-Paris 6, Faculté de Médecine, Site Saint-Antoine, Laboratoire de Bactériologie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Céline Courroux
aLaboratoire de Microbiologie, Hôpital Robert Debré, Service de Microbiologie, Assistance Publique des Hôpitaux de Paris, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume Arlet
cUniversité Pierre et Marie Curie-Paris 6, Faculté de Médecine, Site Saint-Antoine, Laboratoire de Bactériologie, Paris, France
dHôpital Tenon, Service de Bactériologie-Hygiène, Assistance Publique des Hôpitaux de Paris, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edouard Bingen
aLaboratoire de Microbiologie, Hôpital Robert Debré, Service de Microbiologie, Assistance Publique des Hôpitaux de Paris, Paris, France
bUniversité Paris Diderot, Sorbonnes Paris Cité, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.03255-12
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Maternal-fetal Escherichia coli infections, such as neonatal bacteremia and meningitis, are important causes of morbidity and mortality. From 2006 to 2010, we studied newborns and their mothers who were colonized with E. coli in a French hospital in order to document (i) the epidemiology and genetic characteristics of extended-spectrum-beta-lactamase (ESBL)-producing E. coli strains, (ii) the prevalence of associated virulence genes, (iii) the prevalence of clone sequence type 131 (ST131), and (iv) the genetic relationship among ESBL-producing strains. Among the 2,755 E. coli cultures recovered from vaginal or neonatal samples, 68 were ESBL producers (2.46%). We found a wide diversity of ESBL genes, with the majority being bla CTX-M-14, bla CTX-M-1, and bla CTX-M-15, distributed among the 4 main phylogenetic groups. Genes encoding virulence factors were found in 90.7% of the isolates, with ≥2 virulence genes present in 76% of cases. The prevalence of ST131 among ESBL-producing E. coli isolates was 9.4% (6/64). Five of these 6 ST131 isolates possessed bla CTX-M-15 enzymes (and also were resistant to quinolones), and one possessed bla CTX-M-2 enzymes. Two possessed virulence genes, suggesting the presence of pathogenicity island IIJ96 (PAI IIJ96)-like domains. Pulsed-field gel electrophoresis (PFGE) revealed a high level of genomic diversity overall, except for 3 closely related isolates belonging to clonal group ST131. Repetitive PCR showed that the six ST131 isolates were closely related to ST131 control strains (>95% similarity). This study shows a high prevalence of ESBL-producing E. coli strains and clonal group ST131 in the French maternal-fetal population. These results suggest a widespread distribution of ESBL enzymes in the community and highlight the early transmission between mothers and neonates. These findings are worrisome, especially for this particularly vulnerable population.

INTRODUCTION

In the past decade, there has been an alarming increase in antibiotic-resistant Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs), due at least in part to the overuse of broad-spectrum cephalosporins.

The majority of ESBLs identified in clinical isolates during the 1980s to 1990 were of the SHV or TEM type (1). However, since the mid-2000s, CTX-M ESBLs, originating from environmental Kluyvera spp., have gained prominence and are considered pandemic enzymes. CTX-M has been identified in several members of the Enterobacteriaceae family, and especially in Escherichia coli, which has replaced Klebsiella spp. as the principal ESBL-producing member of the Enterobacteriaceae (2–4).

ESBL enzymes are important causes of cephalosporin treatment failure. E. coli strains carrying these enzymes were initially responsible mainly for nosocomial infections, but they have now disseminated into the community. One of the best examples of this trend is the global spread of E. coli clone sequence type 131 (ST131), expressing CTX-M enzymes (5). Maternal-fetal E. coli infections, such as neonatal bacteremia and meningitis, are important causes of morbidity and mortality (6).

The epidemiology of ESBL-producing E. coli strains in adults is well documented (1, 7). In the neonatal period, most studies have focused on hospital-acquired colonization or infection with ESBL-producing E. coli strains (8), leaving aside the epidemiology of community carriage (9). It is necessary to know more about community-acquired infections and particularly about maternal-neonatal transmission to implement empirical therapy (e.g., use of carbapenems in maternity wards where the prevalence of ESBL-producing Enterobacteriaceae is high).

Here, we studied colonized newborns and their mothers who were hospitalized at Robert-Debré Hospital (Paris, France) from 2006 to 2010 in order to document (i) the epidemiology and genetic characteristics of ESBL-producing E. coli strains, (ii) the prevalence of associated virulence genes, (iii) the prevalence of ST131, and (iv) the genetic relation among ESBL-producing strains.

MATERIALS AND METHODS

Setting.We studied samples collected from newborns and/or their mothers at Robert-Debré Pediatric Hospital in Paris, France, over a 5-year period (February 2006 to December 2010). On average, 3,000 women gave birth in our institution each year between 2006 and 2010. Clinically indicated vaginal swabs were obtained from women during the period of childbirth. Birth samples (from gastric fluid, the outer ear, meconium, or the placenta) were taken routinely (<3 h after birth) to detect colonization/infection. This study included all E. coli-positive samples collected from a mother or neonate. When E. coli was isolated on both the mother and child samples, antibiotic susceptibility testing was performed on both of them. Zone diameter inhibition and phenotypes were compared. When they were equal, only one sample per mother-child pair was studied. Some of the isolates studied here have also been used to test the interaction between cefixime and clavulanic acid in vitro (22 isolates) (10).

Isolation, identification, and antibiotic susceptibility testing.All the isolates were routinely cultured at 37°C on Trypticase soy agar, Drigalski agar, and URI4 agar (Bio-Rad, Marnes-la-Coquette, France). Isolates were identified with the API 20E system (bioMérieux, Marcy l'Etoile, France).

Antibiotic susceptibility was determined with the standard disk diffusion method on Mueller-Hinton agar (Bio-Rad, Marnes-la-Coquette, France) according to CLSI guidelines (11). All the isolates were tested for susceptibility to amoxicillin, ticarcillin, cefepime, ticarcillin-clavulanic acid, cephalothin, ceftazidime, amoxicillin-clavulanic acid, cefotaxime, ertapenem, cefoxitin, moxalactam, imipenem, ofloxacin (OFLO), gentamicin (GEN), and trimethoprim-sulfamethoxazole (SXT). ESBL detection was performed by using the double-disk synergy test between clavulanic acid and extended-spectrum cephalosporins (ceftazidime and cefotaxime) on Mueller-Hinton agar (12).

Molecular characterization of beta-lactamases.Strains with a positive double-disk synergy test result were further studied by specific PCR amplification and sequencing of ESBL genes. Lysates were obtained by boiling under standard conditions. The PCR primers and assay methods are described in detail elsewhere (13). CTX-M-type beta-lactamases were checked using the method of Eckert et al. (14).

Phylogenetic background and virulence gene analysis.The E. coli strains were assigned to one of the four main phylogenetic groups (A, B1, B2, and D) by using a previously described multiplex PCR method (15) that uses a combination of 3 DNA markers (chuA, yjaA, and TSPE4.C2). Using a PCR-based method, the strains were also screened for 11 genes encoding the following putative virulence factors (VFs): fyuA, iron uptake; hly, hemolysin; sfa/foc, S or F1C fimbriae; papC genes of P fimbriae operons; iucC, aerobactin; papG (II and III alleles); cnf1, cytotoxic necrotizing factor; iroN, salmochelin receptor; ibeA, putative invasin; hra, heat-resistant agglutinin; and the capsular antigen K1 (16, 17).

Pulsed-field gel electrophoresis.All E. coli isolates were typed by pulsed-field gel electrophoresis (PFGE) on the CHEF DRII system (Bio-Rad, Marnes-la-Coquette, France) using genomic DNA digested with NotI (18). A dendrogram was constructed using the Dice similarity coefficient, and the unweighted-pair group method using average linkages (UPGMA) algorithm was used to cluster the strains.

Detection of ST131.Allele-specific PCR of the pabB and trpA alleles was used to detect B2 strains belonging to the pandemic clone O25b:H4-ST131 (19). Four strains known to belong to clone ST131 were used as positive controls (e.g., strain TN03 [20]).

Repetitive PCR.For strains belonging to clone ST131 (as determined by PCR), clonal relatedness was determined by using the DiversiLab semiautomated repetitive-sequence-based PCR (rep-PCR) typing method as described previously (21, 22). Four strains known to belong to clone ST131 were used as controls.

RESULTS

During the 5-year study period, 2,755 E. coli isolates were recovered from neonatal samples (about 2,000 samples were obtained each year, each collected <3 h after birth) or from maternal vaginal samples (about 2,500 samples each year). A total of 68 ESBL-producing E. coli isolates were identified (2.46%). Four strains did not grow in culture after being frozen. Twenty-eight (44%) of the ESBL-producing strains were obtained from vaginal swabs and 36 (56%) from neonatal samples (from gastric fluid or the outer ear). When inhibition zone diameters of antibiotics and antibiotypes were equal for both isolates from the mother and neonate, only one sample per mother-child pair was studied; the inhibition zone diameters were found to be the same in each case.

No significant variation in the total number of E. coli isolates was observed between 2006 and 2010. In contrast, the prevalence of ESBL-producing E. coli of all E. coli isolates rose from 1.1% (6/523) in 2006 to 4.1% (22/543) in 2010 (P < 0.05).

Phylogenetic diversity.The ESBL-producing E. coli isolates belonged to phylogenetic group A (n = 22), B1 (n = 8), B2 (n = 15), or D (n = 19).

Beta-lactamase genes.Of the 64 ESBL-producing E. coli isolates, 84.3% were positive for blaCTX-M genes, 9.4% for blaSHV genes, and 6.3% for blaTEM genes. The CTX-M types were as follows: 19 blaCTX-M-14 (29.7%), 17 blaCTX-M-1 (26.5%), 12 blaCTX-M-15 (18.8%), 3 blaCTX-M-2 (4.7%), 1 blaCTX-M-3 (1.6%), 1 blaCTX-M-57 (1.6%), and 1 blaCTX-M-27 (1.6%). There were 4 blaTEM-52 and 4 blaSHV-12 (6.3% each, respectively) and 2 blaSHV-2a (3.1%) genes.

The CTX-M-producing E. coli isolates belonged to groups A (17/54, 31.5%), B1 (7/54, 13%), B2 (13/54, 24%), and D (17/54, 31.5%). We noted that 8/12 (67%) of blaCTX-M-15 genes were found in group B2, and 8/19 (42%) blaCTX-M-14 genes were found in group D.

Additionally, 21 (33%) of the ESBL-producing isolates also possessed blaTEM-1, and 5 (8%) also possessed blaOXA-1.

Thirty-one (48.4%) of the 64 isolates were resistant to SXT, 21 (32.8%) were resistant to quinolones (nalidixic acid and ofloxacin), 12 (18.8%) were resistant to gentamicin, and 7 (11%) were resistant to all 3 families of antibiotics. All the isolates were susceptible to imipenem and ertapenem, defined according to the CLSI guidelines (11).

Virulence genes.All but 6 (9.3%) of the isolates possessed at least one virulence gene, and 49/64 (76%) possessed at least two. Four of the 6 strains with no virulence gene belonged to phylogenetic group A, one to group B1, and one to group D.

The prevalences of the virulence genes were as follows: fyuA, 70%; iucC, 65%; iroN, 37%; papC, 34%; papGII, 26%; hra, 25%; hly, 11%; cnf1, 6%; papGIII, 5%; and sfa, 5%. The gene of the capsular antigen K1 was possessed by 14/64 isolates (22%) (Table 1).

View this table:
  • View inline
  • View popup
Table 1

Characteristics of isolates obtained through mother and newborn samples in this study

The most frequent combination of virulence genes was fyuA, papC, iucC, and papGII, which was found in 8 isolates, of which 6 belonged to phylogenetic group D.

PFGE revealed a high level of genomic diversity, except for 3 isolates (E. coli ST131 31342, 29369, and 30151) belonging to phylogenetic group B2 ST131, which were all closely related according to Tenover's criteria (23). As an example, a dendrogram showing the genetic relation within group B2 is provided in Fig. 1.

Fig 1
  • Open in new tab
  • Download powerpoint
Fig 1

Genetic relation among the 13 ESBL-producing E. coli strains in group B2, as determined by PFGE (the pulsotype could not be obtained for 1 strain). The framed isolates are those belonging to clonal group ST131. These 6 isolates yielded 4 different profiles.

The PFGE pulsotype could not be obtained for 7 isolates, despite several attempts.

ST131.The prevalence of ST131 was 9.4% (6/64) overall and 43% among B2 isolates. Five ST131 strains possessed blaCTX-M-15 and one possessed blaCTX-M-2. The 5 strains possessing blaCTX-M-15 were resistant to quinolones, and 4 were resistant to trimethoprim-sulfamethoxazole.

All six ST131 strains possessed the fyuA and iucC virulence genes.

Repetitive PCR.DiversiLab analysis showed that the six E. coli ST131 strains (isolates 26601, 27144, 28678, 29369, 30151, and 31342) were closely related to the ST131 control strains (>95% similarity) (Fig. 2).

Fig 2
  • Open in new tab
  • Download powerpoint
Fig 2

Genetic relatedness of E. coli strains belonging to clonal group O25b:H4-ST131 and control strains, as determined with DiversiLab semiautomated rep-PCR typing. There are 4 control strains known to belong to ST131 and 4 unrelated control strains that do not belong to clonal group ST131. E. coli ST131 isolates 29369, 28678, 26601, 31342, 27144, and 30151 are those found in this maternal-fetal study. The six E. coli ST131 strains in our study were closely related to the ST131 control strains (>95% similarity) and exhibited a >15% difference with strains not belonging to this sequence type.

DISCUSSION

This study shows an increase in the prevalence of ESBL-producing strains among E. coli isolates recovered from neonates or their mothers in a French hospital between 2006 and December 2010, which rose from 1.15% (6/523) in 2006 to 4.1% (22/543) in 2010. This increase is in keeping with the global rise in ESBL-producing E. coli carriage in the general population (3, 24, 25).

Note that the prevalence of ESBL-producing E. coli carriage might have been underestimated in this study, because not all mothers or neonates were sampled. blaCTX-M-14, blaCTX-M-1, and blaCTX-M-15 were the principal ESBLs found in this study, representing 29.7%, 26.5%, and 18.8% of all ESBLs, respectively. These results are similar to those reported in adults (26, 27). In contrast, they differ from those obtained in children from Asia and South America (28, 29) and particularly from those obtained in the North American pediatric study by Chandramohan et al. (30), who found 60% blaCTX-M-15, 14.3% blaCTX-M-14, and 2.1% blaCTX-M-27 ESBLs. In addition, CTX-M diversity was higher in our study, with the presence of CTX-M-1, -14, -15, -3, -2, -27, and -57 (28–30).

blaCTX-M-15 has been reported worldwide, whereas blaCTX-M-1 and blaCTX-M-14 seem to have specific geographic distributions in adults. A recent epidemiological study showed the presence of these enzymes in adults in France (31).

Virulent extraintestinal strains mainly belong to groups B2 and D, whereas commensal strains mainly belong to groups A and B1 (32). The majority of the strains studied here belonged to groups A and D, followed by groups B2 and B1. Overall, roughly half the strains belonged to groups B2/D and half to groups A/B1. Strains with blaCTX-M-1, blaCTX-M-14, and blaCTX-M-15 belonged to phylogenetic groups A, B2, and D. Interestingly, 67% of the strains possessing blaCTX-M-15 belonged to group B2 and, of these, 5 belonged to clone ST131. These results are consistent with a recent report on blaCTX-M-15 (30).

Half the blaTEM-52-possessing isolates belonged to group B2 and half to group A (4 strains in total). Over 90% of the strains in our study possessed at least one virulence gene, and 76% possessed at least two. Virulence genes were found in all the phylogenetic groups studied.

This study highlights the high proportion of E. coli strains belonging to sequence type 131. Indeed, 6 of the 14 B2 strains belonged to O25b:H4-ST131, representing 9.4% of all ESBL-producing isolates (and 43% of all B2 strains). This proportion is similar to that found by Chandramohan and Revell (30) in a pediatric study, in which 10.2% of E. coli isolates belonged to clone ST131. This sequence type was identified with a PCR-based method (19) and confirmed with rep-PCR (21, 22). All our strains belonging to clonal group ST131 had a unique rep-PCR profile with >95% similarity, whereas PFGE divided them into 4 pulsotypes. This confirms that PFGE is more discriminatory than rep-PCR (22).

Clone ST131 has spread widely and is often reported in adults (33) but rarely in infants and children (30). To our knowledge, our study is the first to provide information about ST131 in the neonatal population, showing early transmission between mothers and neonates. E. coli ST131 is typically multidrug-resistant, including a resistance to fluoroquinolones. This was the case of 5 of the 6 ST131 strains in our study. In addition, 4 of them possessed blaOXA-1. Clone ST131 is most frequently described as producing the plasmid-mediated ESBL CTX-M-15 (this was the case in 5 of our 6 strains), although the production of other ESBL types, such as SHV-12, has also been reported (34).

blaCTX-M-15 and E. coli ST131 have emerged and expanded during the past decade in the United States (35) in both children and adults. One possible reason for the striking epidemiological success of blaCTX-M-15 and ST131 might be their association. Indeed, the ST131 clone has adapted well to humans (20), and this has contributed to the worldwide dissemination of efficient resistance to third-generation cephalosporins: blaCTX-M-15. Some studies suggest that clone ST131 is virulent: like other B2 isolates, it killed 100% of experimental mice in another study (36). Van der Bij et al. (37) also reported that ST131 had a significantly higher virulence score than did other extraintestinal pathogenic E. coli (ExPEC) STs. In contrast, other studies have found that ST131 is not highly virulent in infection models and that it differs from classical ExPEC group B2 strains by the absence of several virulence genes, such as hlyA and cnf1 (38). It appears that few virulence genes are consistently present in this clone (39).

As stated above, ST131 isolates can be subdivided by means of PFGE (40). It is therefore possible that ST131 variants might have different virulence profiles and capacities for spread. In our study, the 3 clones that had the same pulsotype seemed to possess more virulence genes than did the others, and 2 of them harbored papGII, cnfI, hra, and hly, suggesting the presence of PAI IIJ96-like domains (16). Interestingly, only one other strain, not belonging to the ST131 clone, possessed a putative PAI IIJ96-like domain. Clone ST131 might thus have found an optimal balance between virulence, colonization, and resistance (20).

PFGE revealed a high genomic diversity among our blaTEM-, blaSHV-, and blaCTX-M-type ESBL E. coli isolates. This diversity illustrates the high capacity for spread among different genetic backgrounds found in the community, accomplished via mobile conjugative elements.

Together, our results suggest that the carriage of ESBL-producing E. coli isolates in French children and their mothers results from community acquisition of these bacteria or their genes encoding ESBLs. The high proportion of strains possessing blaCTX-M-type ESBLs, together with the high prevalence of clonal group ST131 in the North American pediatric study reported by Chandramohan et al. and in our neonatal French study, shows the worldwide diffusion of these CTX-M genes and this clone in pediatric populations. Although person-to-person transmission might contribute to ESBL dissemination, as suggested by Rodriguez-Baño et al. (41), the reservoir might be the family, which would explain the transmission from parents to their children as observed in our study. The spread of ESBL-producing E. coli strains in the community, especially during the neonatal period, is a cause for concern. Elevated carriage rates necessitate strict hygiene measures, both in the hospital and at home. More-discriminatory use of antibiotics is needed to limit the dissemination of these resistant strains.

FOOTNOTES

    • Received 11 December 2012.
    • Returned for modification 13 February 2013.
    • Accepted 15 March 2013.
    • Accepted manuscript posted online 20 March 2013.
  • Copyright © 2013, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Paterson DL,
    2. Bonomo RA
    . 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657–686.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Cantón R,
    2. Coque TM
    . 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466–475.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Pitout JD,
    2. Laupland KB
    . 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159–166.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Pitout JD,
    2. Nordmann P,
    3. Laupland KB,
    4. Poirel L
    . 2005. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52–59.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Rogers BA,
    2. Sidjabat HE,
    3. Paterson DL
    . 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1–14.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Boyer-Mariotte S,
    2. Duboc P,
    3. Bonacorsi S,
    4. Lemeland JF,
    5. Bingen E,
    6. Pinquier D
    . 2008. CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy. J. Antimicrob. Chemother. 62:1472–1474.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Courpon-Claudinon A,
    2. Lefort A,
    3. Panhard X,
    4. Clermont O,
    5. Dornic Q,
    6. Fantin B,
    7. Mentré F,
    8. Wolff M,
    9. Denamur E,
    10. Branger C
    . 2011. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin. Microbiol. Infect. 17:557–565.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Shakil S,
    2. Akram M,
    3. Ali SM,
    4. Khan AU
    . 2010. Acquisition of extended-spectrum beta-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors. J. Med. Microbiol. 59:948–954.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Blaschke AJ,
    2. Korgenski EK,
    3. Daly JA,
    4. LaFleur B,
    5. Pavia AT,
    6. Byington CL
    . 2009. Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience. Am. J. Infect. Control 37:435–441.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Bingen E,
    2. Bidet P,
    3. Birgy A,
    4. Sobral E,
    5. Mariani P,
    6. Cohen R
    . 2012. In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-beta-lactamase-producing Escherichia coli causing urinary tract infection. J. Clin. Microbiol. 50:2540–2541.
    OpenUrlFREE Full Text
  11. 11.↵
    Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
  12. 12.↵
    1. Drieux L,
    2. Brossier F,
    3. Sougakoff W,
    4. Jarlier V
    . 2008. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin. Microbiol. Infect. 14(Suppl 1):90–103.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Dallenne C,
    2. Da Costa A,
    3. Decre D,
    4. Favier C,
    5. Arlet G
    . 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65:490–495.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Eckert C,
    2. Gautier V,
    3. Saladin-Allard M,
    4. Hidri N,
    5. Verdet C,
    6. Ould-Hocine Z,
    7. Barnaud G,
    8. Delisle F,
    9. Rossier A,
    10. Lambert T,
    11. Philippon A,
    12. Arlet G
    . 2004. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother. 48:1249–1255.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Clermont O,
    2. Bonacorsi S,
    3. Bingen E
    . 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555–4558.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Bingen-Bidois M,
    2. Clermont O,
    3. Bonacorsi S,
    4. Terki M,
    5. Brahimi N,
    6. Loukil C,
    7. Barraud D,
    8. Bingen E
    . 2002. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect. Immun. 70:3216–3226.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Bidet P,
    2. Mahjoub-Messai F,
    3. Blanco J,
    4. Blanco J,
    5. Dehem M,
    6. Aujard Y,
    7. Bingen E,
    8. Bonacorsi S
    . 2007. Combined multilocus sequence typing and O serogrouping distinguishes Escherichia coli subtypes associated with infant urosepsis and/or meningitis. J. Infect. Dis. 196:297–303.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Bonacorsi SPP,
    2. Clermont O,
    3. Tinsley C,
    4. Le Gall I,
    5. Beaudoin JC,
    6. Elion J,
    7. Nassif X,
    8. Bingen E
    . 2000. Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect. Immun. 68:2096–2101.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Clermont O,
    2. Dhanji H,
    3. Upton M,
    4. Gibreel T,
    5. Fox A,
    6. Boyd D,
    7. Mulvey MR,
    8. Nordmann P,
    9. Ruppé E,
    10. Sarthou JL,
    11. Frank T,
    12. Vimont S,
    13. Arlet G,
    14. Branger C,
    15. Woodford N,
    16. Denamur E
    . 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274–277.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Vimont S,
    2. Boyd A,
    3. Bleibtreu A,
    4. Bens M,
    5. Goujon JM,
    6. Garry L,
    7. Clermont O,
    8. Denamur E,
    9. Arlet G,
    10. Vandewalle A
    . 2012. The CTX-M-15-producing Escherichia coli clone O25b:H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7:e46547. doi:10.1371/journal.pone.0046547.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Pitout JD,
    2. Campbell L,
    3. Church DL,
    4. Wang PW,
    5. Guttman DS,
    6. Gregson DB
    . 2009. Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15. J. Clin. Microbiol. 47:1212–1215.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Lau SH,
    2. Cheesborough J,
    3. Kaufmann ME,
    4. Woodford N,
    5. Dodgson AR,
    6. Dodgson KJ,
    7. Bolton EJ,
    8. Fox AJ,
    9. Upton M
    . 2009. Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the DiversiLab repetitive sequence-based PCR system. Clin. Microbiol. Infect. 16:232–237.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Tenover FC,
    2. Arbeit RD,
    3. Goering RV,
    4. Mickelsen PA,
    5. Murray BE,
    6. Persing DH,
    7. Swaminathan B
    . 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233–2239.
    OpenUrlFREE Full Text
  24. 24.↵
    1. Cantón R,
    2. Novais A,
    3. Valverde A,
    4. Machado E,
    5. Peixe L,
    6. Baquero F,
    7. Coque TM
    . 2008. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 14(Suppl 1):144–153.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Birgy A,
    2. Cohen R,
    3. Levy C,
    4. Bidet P,
    5. Courroux C,
    6. Benani M,
    7. Thollot F,
    8. Bingen E
    . 2012. Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children. BMC Infect. Dis. 12:315. doi:10.1186/1471-2334-12-315.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Valverde A,
    2. Coque TM,
    3. Sánchez-Moreno MP,
    4. Rollán A,
    5. Baquero F,
    6. Cantón R
    . 2004. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microbiol. 42:4769–4775.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Hawkey PM
    . 2008. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin. Microbiol. Infect. 14(Suppl 1):159–165.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Wu TL,
    2. Chia JH,
    3. Su LH,
    4. Kuo AJ,
    5. Chu C,
    6. Chiu CH
    . 2003. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J. Clin. Microbiol. 41:4836–4838.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Pallecchi L,
    2. Malossi M,
    3. Mantella A,
    4. Gotuzzo E,
    5. Trigoso C,
    6. Bartoloni A,
    7. Paradisi F,
    8. Kronvall G,
    9. Rossolini GM
    . 2004. Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob. Agents Chemother. 48:4556–4561.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Chandramohan L,
    2. Revell PA
    . 2012. Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population. Antimicrob. Agents Chemother. 56:4765–4770.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Brisse S,
    2. Diancourt L,
    3. Laouenan C,
    4. Vigan M,
    5. Caro V,
    6. Arlet G,
    7. Drieux L,
    8. Leflon-Guibout V,
    9. Mentré F,
    10. Jarlier V,
    11. Nicolas-Chanoine MH
    , Coli β Study Group. 2012. Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J. Clin. Microbiol. 50:2974–2981.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Branger C,
    2. Zamfir O,
    3. Geoffroy S,
    4. Laurans G,
    5. Arlet G,
    6. Thien HV,
    7. Gouriou S,
    8. Picard B,
    9. Denamur E
    . 2005. Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg. Infect. Dis. 11:54–61.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Nicolas-Chanoine MH,
    2. Blanco J,
    3. Leflon-Guibout V,
    4. Demarty R,
    5. Alonso MP,
    6. Canica MM,
    7. Park YJ,
    8. Lavigne JP,
    9. Pitout J,
    10. Johnson JR
    . 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273–281.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Oteo J,
    2. Cercenado E,
    3. Fernández-Romero S,
    4. Saéz D,
    5. Padilla B,
    6. Zamora E,
    7. Cuevas O,
    8. Bautista V,
    9. Campos J
    . 2012. Extended-spectrum-β-lactamase-producing Escherichia coli as a cause of pediatric infections: report of a neonatal intensive care unit outbreak due to a CTX-M-14-producing strain. Antimicrob. Agents Chemother. 56:54–58.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Johnson JR,
    2. Urban C,
    3. Weissman SJ,
    4. Jorgensen JH,
    5. Lewis JS Jr,
    6. Hansen G,
    7. Edelstein PH,
    8. Robicsek A,
    9. Cleary T,
    10. Adachi J,
    11. Paterson D,
    12. Quinn J,
    13. Hanson ND,
    14. Johnston BD,
    15. Clabots C,
    16. Kuskowski MA
    , AMERECUS Investigators. 2012. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56:2364–2370.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Clermont O,
    2. Lavollay M,
    3. Vimont S,
    4. Deschamps C,
    5. Forestier C,
    6. Branger C,
    7. Denamur E,
    8. Arlet G
    . 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024–1028.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Van der Bij AK,
    2. Peirano G,
    3. Pitondo-Silva A,
    4. Pitout JD
    . 2012. The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. Diagn. Microbiol. Infect. Dis. 72:297–302.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Lavigne JP,
    2. Vergunst AC,
    3. Goret L,
    4. Sotto A,
    5. Combescure C,
    6. Blanco J,
    7. O'Callaghan D,
    8. Nicolas-Chanoine MH
    . 2012. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7:e34294. doi:10.1371/journal.pone.0034294.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Coelho A,
    2. Mora A,
    3. Mamani R,
    4. López C,
    5. González-López JJ,
    6. Larrosa MN,
    7. Quintero-Zarate JN,
    8. Dahbi G,
    9. Herrera A,
    10. Blanco JE,
    11. Blanco M,
    12. Alonso MP,
    13. Prats G,
    14. Blanco J
    . 2011. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J. Antimicrob. Chemother. 66:517–526.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Peirano G,
    2. Pitout JD
    . 2010. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316–321.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Rodriguez-Baño J,
    2. López-Cerero L,
    3. Navarro MD,
    4. Díaz de Alba P,
    5. Pascual A
    . 2008. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J. Antimicrob. Chemother. 62:1142–1149.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Characterization of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Strains Involved in Maternal-Fetal Colonization: Prevalence of E. coli ST131
André Birgy, Patricia Mariani-Kurkdjian, Philippe Bidet, Catherine Doit, Nathalie Genel, Céline Courroux, Guillaume Arlet, Edouard Bingen
Journal of Clinical Microbiology May 2013, 51 (6) 1727-1732; DOI: 10.1128/JCM.03255-12

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Strains Involved in Maternal-Fetal Colonization: Prevalence of E. coli ST131
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Characterization of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Strains Involved in Maternal-Fetal Colonization: Prevalence of E. coli ST131
André Birgy, Patricia Mariani-Kurkdjian, Philippe Bidet, Catherine Doit, Nathalie Genel, Céline Courroux, Guillaume Arlet, Edouard Bingen
Journal of Clinical Microbiology May 2013, 51 (6) 1727-1732; DOI: 10.1128/JCM.03255-12
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X